美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Provectus生物製藥

0.0617

-0.0001-0.10%

成交量：11.21萬

成交額：6,919.11

市值：2,593.13萬

市盈率：-4.65

高：0.0620

開：0.0618

低：0.0617

收：0.0618

52周最高：0.1050

52周最低：0.0380

股本：4.20億

流通股本：3.87億

量比：4.53

換手率：0.03%

股息：- -

股息率：- -

每股收益(TTM):-0.0133

每股收益(LYR):-0.0213

淨資產收益率：22.69%

總資產收益率：-501.90%

市淨率：-3.85

市盈率(LYR):-2.89

資料載入中...

總覽公司新聞公告

公司資料

公司名字：

Provectus生物製藥

交易所：

OTCQB

成立時間：

2002

員工人數：

6

公司地址：

800 South Gay Street,Suite 1610,Knoxville,Tennessee,United States

官網：

http://www.pvct.com

郵編：

37929

電話：

傳真：

866 998 0005

簡介：

Provectus Biopharmaceuticals, Inc.於2002年在特拉華成立，連同它的六個全資子公司和一個控股公司管理在一個綜合的基礎上，本文所指的是一個發展階段的生物製藥公司，主要從事發展民族醫藥腫瘤和皮膚病。公司的目標是開發出更安全，更有效的替代治療，比傳統的治療方法，創傷小、更經濟。公司開發並打算許可證或市場和銷售的兩種處方藥的候選人，光伏- 10和PH - 10。

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/PVCT/company"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PVCT","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PVCT\",,,,,undefined,":{"symbol":"PVCT","market":"US","secType":"STK","nameCN":"Provectus生物製藥","latestPrice":0.0617,"timestamp":1781710980000,"preClose":0.06176,"halted":0,"volume":112066,"delay":15,"changeRate":-0.0009715025906736479,"floatShares":386656900,"shares":420279879,"eps":-0.013279,"marketStatus":"交易中","change":-0.00006,"latestTime":"06-17 11:43:00 EDT 延時","open":0.06176,"high":0.062,"low":0.0617,"amount":6919.112180664,"amplitude":0.004858,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":-0.013279,"tradingStatus":2,"nextMarketStatus":{"tag":"盤後交易","tradingStatus":3,"beginTime":1781726400000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"OTCQB","adjPreClose":0.06176,"volumeRatio":4.529352},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PVCT\",,,,,undefined,":{"symbol":"PVCT","floatShares":386656900,"roa":"-501.90%","roe":"22.69%","lyrEps":-0.021324,"volumeRatio":4.529352,"shares":420279879,"dividePrice":0,"high":0.062,"amplitude":0.004858,"preClose":0.06176,"low":0.0617,"week52Low":0.038,"pbRate":"-3.85","psRate":"451.14","week52High":0.105,"institutionHeld":0.0006,"latestPrice":0.0617,"eps":-0.013279,"divideRate":0,"volume":112066,"delay":15,"ttmEps":-0.013279,"open":0.06176,"prevYearClose":0.0559,"prevWeekClose":0.0606,"prevMonthClose":0.065,"prevQuarterClose":0.0509,"fiveDayClose":0.0686,"twentyDayClose":0.0661,"sixtyDayClose":0.0509},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PVCT\",params:#limit:5,,,undefined,":[{"market":"US","date":"2024-11-12","symbol":"PVCT","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1731387600000,"reportTimeType":"","actualEps":null},{"market":"US","date":"2024-08-13","symbol":"PVCT","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1723521600000,"reportTimeType":"","actualEps":null},{"market":"US","date":"2024-05-14","symbol":"PVCT","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1715659200000,"reportTimeType":"","actualEps":null},{"market":"US","date":"2024-03-28","symbol":"PVCT","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1711598400000,"reportTimeType":"","actualEps":null},{"market":"US","date":"2024-02-22","symbol":"PVCT","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1708578000000,"reportTimeType":"","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PVCT\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PVCT\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":2336891,"yearFounded":2002,"employeeNum":6,"address":"800 South Gay Street,Suite 1610,Knoxville,Tennessee,United States","zipCode":"37929","officePhone":"866 594 5999","officeFax":"866 998 0005","fiscalYearEnd":"12-31"},"stockCompanyDetail":{"websiteUrl":"http://www.pvct.com","stockEarnings":[{"period":"1week","weight":-0.0318},{"period":"1month","weight":-0.0603},{"period":"3month","weight":-0.1125},{"period":"6month","weight":0.1692},{"period":"1year","weight":-0.1469},{"period":"ytd","weight":0.278}],"description":"Provectus Biopharmaceuticals, Inc.於2002年在特拉華成立，連同它的六個全資子公司和一個控股公司管理在一個綜合的基礎上，本文所指的是一個發展階段的生物製藥公司，主要從事發展民族醫藥腫瘤和皮膚病。公司的目標是開發出更安全，更有效的替代治療，比傳統的治療方法，創傷小、更經濟。公司開發並打算許可證或市場和銷售的兩種處方藥的候選人，光伏- 10和PH - 10。","exchange":"OTCQB","name":"Provectus生物製藥","nameEN":"Provectus Biopharmaceuticals, Inc."}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"PVCT\",market:\"US\",,,undefined,":null}}